CIK: 0001833486 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value ($000): $706,508 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | NGM Biopharmaceuticals Inc | 15,396,116 | $303,611 | 43.0% | $30.30 | — | COM | 62921N105 |
| — | RAPT Therapeutics Inc | 3,885,679 | $123,526 | 17.5% | $19.75 | — | COM | 75382E109 |
| RVMD | Revolution Medicines Inc | 3,347,245 | $106,242 | 15.0% | $39.54 | -11.7% | COM | 76155X100 |
| — | Constellation Pharmaceuticals Inc. | 2,626,631 | $88,780 | 12.6% | $28.80 | — | COM | 210373106 |
| ORIC | ORIC Pharmaceuticals Inc. | 4,768,181 | $84,349 | 11.9% | $28.69 | -23.6% | COM | 68622P109 |